David Thomson
Conseiller Juridique Général chez MANNKIND CORPORATION
Fortune : 4 M $ au 31/05/2024
Postes actifs de David Thomson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MANNKIND CORPORATION | Conseiller Juridique Général | 01/01/2002 | - |
| Secrétaire Général | 01/01/2002 | - | |
QrumPharma, Inc.
 QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology QrumPharma, Inc. is engaged in developing drug products. It develops inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease. The company was founded by Thomas Hofmann and is headquartered in Doylestown, PA. | Corporate Officer/Principal | - | - |
Historique de carrière de David Thomson
Formation de David Thomson
| Queen's University | Doctorate Degree |
| University of Toronto | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Canada | 3 |
Opérationnelle
| Graduate Degree | 2 |
| General Counsel | 1 |
| Corporate Secretary | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MANNKIND CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
QrumPharma, Inc.
QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology QrumPharma, Inc. is engaged in developing drug products. It develops inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease. The company was founded by Thomas Hofmann and is headquartered in Doylestown, PA. | Health Technology |
- Bourse
- Insiders
- David Thomson
- Expérience
